Tevogen Bio Holdings Inc. (TVGN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on April 17, 2025, by Tevogen Bio Holdings Inc., a Delaware corporation and emerging growth company. The filing discloses a material agreement entered into on the same date to support the company's cell therapy product production.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a contractual agreement rather than periodic financial results.
Material Changes and Agreements
- Master Services and Facilities Agreement: Tevogen entered into an agreement with CD 8 Technology Services LLC ("CD8") to access specialized manufacturing facilities, including clean rooms and laboratories, and related operational services.
- Terms: The agreement has an initial term of 12 months with automatic renewal for additional 12-month periods unless terminated.
- Cost Structure: Specific costs, scope of work, and timelines will be defined in individual project work orders rather than the master agreement.
- Related Party Transaction: CD8 is associated with Dr. Manmohan Patel, who beneficially owns more than 5% of Tevogen's common stock.
Outlook, Risks, and Management Commentary
Management announced the agreement via a press release (Exhibit 99.1) to support the production of Tevogen's cell therapy products. The filing does not contain specific forward-looking guidance, risk factors, or contingencies beyond the standard terms of the agreement and the related party nature of the transaction.
Key Facts for Investor Verification
- Verify the specific costs and scope of work in the individual project work orders referenced in the agreement.
- Review the full text of the press release (Exhibit 99.1) for additional strategic context.
- Confirm the extent of Dr. Manmohan Patel's beneficial ownership and any other potential conflicts of interest with CD8.
- Monitor future filings for the execution of specific work orders and their impact on cash burn.